Search

everythinglearnresearchcommunity

for

Search:↓

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

Healthy scalp reduces hair loss by managing oxidative stress.

CD4+ skin cells may be precursors to basal cell carcinoma.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Blocking LFA-1 prevents hair loss in mice.

The document concludes that adult mammalian skin contains multiple stem cell populations with specific markers, important for understanding skin regeneration and related conditions.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

Using neurohormones to control keratin can lead to new skin disease treatments.

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Porcine acellular dermal matrix treatment helps wounds heal faster and reduces scarring by affecting Jag1 in skin stem cells.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.